Cotton bedding is notorious for accumulating harmful bacteria and retaining moisture that causes inflammation and breakouts. Lifeloom’s soothing pillowcases with DermaTherapy fabric technology has been clinically proven to reduce inflammatory acne by over 49% when compared to traditional cotton pillowcases.
The Department of Dermatology, School of Medicine at Wake Forest University completed a 12-week clinical trial involving participants who had facial acne. Both standard pillowcases and Lifeloom's medical-grade pillowcases with DermaTherapy technology were used by patients. Compared to standard pillowcase users, participants who used our pillowcases experienced:
"This bedding is the absolute best investment! They have helped me with an ongoing acne issue I’ve had into early adulthood. It’s crazy to think sheets were the answer over all kinds of skincare creams. I sleep better and look and feel great each and every day."
Lifeloom’s bedding uses DermaTherapy® fabric technology, which is woven from a strong, continuous-filament yarn that creates a consistently smooth, silk-like surface. Our fabrics are lint free and release almost no contaminating particles that can irritate the skin and infiltrate pores. Most importantly to those experiencing facial or body acne, friction and skin abrasiveness are virtually eliminated while moisture is wicked away from the fabric.
Lifeloom's DermaTherapy® fabric technology has been tested many times for skin sensitivity as it may relate to concerns from those suffering with acne. These tests included analyses of skin irritation, skin sensitization, and cytotoxicity. In all such testing, the fabric showed passing results, with no cytotoxicity or sensitivity for at-risk skin. The FDA reviewed test results and found them to pass standards for medical devices used in contact with the skin.
* Standard No. ISO 10993-5, “Biological Assessment of Medical Products, Part 5: Tests for Cytotoxicity – MEM Elution; Version 10993-5”, Standard Date 01/01/1999
* Standard No. ISO 10993-10, “Biological Evaluation of Medical Devices – Part 10: Irritation: Intracutaneous Reactivity; Version 10993-10:2002(E)”, Standard Date 01/01/2002
* Standard No. ISO 10993-10, “Biological Evaluation of Medical Devices – Part 10: Tests for Irritation and Sensitization – Maximum Sensitization
Test; Version10993-10:2002(E)”, Standard Date 01/01/2002
Lifeloom’s bedding is crafted from DermaTherapy® fabric technology, and is woven from a blend of polyester and nylon yarns.
Our FDA-cleared bedding is made in the United States.
The DermaTherapy® fabric technology is crafted from woven fibers with unique cross sections that create micro-channels. These micro-channels carry–or “wick”–moisture away from skin, keeping your skin fresh and pores clean.
Initial results are typically seen within 2-3 weeks.
All Lifeloom bedding made with DermaTherapy® fabric technology meet the strictest standards of quality as defined by our stringent ISO 9001 certification. You can expect to realize the mitigating benefits of our bedding within 2–3 weeks. Should you become dissatisfied with your purchase for any reason, Lifeloom will accept a return within 90 days of date-of-purchase. Customer is responsible for return shipping, and returns will be refunded in the original method of payment. It is recommended to use a tracking number when returning product.
All linens crafted using DermaTherapy® technology include a one-year warranty against manufacturer defects.